Komori
Earnings presentation7743SEED CO.,LTD.Electrical Equipment and Precision Instruments

Third-Quarter Financial Results Briefing Materials for the Fiscal Year Ending March 2026

For the third quarter of the fiscal year ending March 2026, revenue, operating profit, ordinary profit and net profit all exceeded the year-earlier levels. Delivery delays for astigmatism-correcting lenses were resolved, while expenses increased due to additional staffing, base-pay increases and the launch of a logistics center, among other factors.

Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
27
¥ millions (year-on-year change in operating income)
Wording
Conditional
How definitive the wording is.

Contents of this document

Earnings presentationFiscal year ending March 2026, third quarter12 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales25,523 million yen+1.3%
Operating profit1,294 million yen+2.2%
Ordinary income1,310 million yen+9.6%
Net income¥905 million +9.8%profit attributable to owners of the parent
Gross Profit Margin44.9%
Operating profit margin5.1%
Selling, general and administrative expenses10,157 million yen
Full-year earnings forecast
Net Sales
37,000 million yen
Operating profit
2,000 million yen
Ordinary income
1,600 million yen
Profit attributable to owners of the parent
1,100 million yen
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales69.0%
Operating profit64.7%
Ordinary income81.9%
Profit attributable to owners of parent for the quarter82.3%
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Gross profit+¥516 million
Increase in selling, general and administrative expenses-¥488 million
Increase in non-operating income+¥136 million
Increase in non-operating expenses-¥49 million
Increase in extraordinary income+¥77 million
Decrease in extraordinary losses+¥1 million
Increase in taxes and other items-¥112 million
New initiatives
  • 鴻巣研究所4号棟の竣工と生産能力増強
  • AI検査・省人化生産ラインの導入
  • 高酸素透過性シリコーンハイドロゲル乱視用レンズの発売
  • ヒロインメイク1day UV Mの新色発売
  • SEEDこどものめ未来プロジェクトの開始
  • Application to change the market segment to the Tokyo Stock Exchange Standard Market
Key KPIsA metric the company considers important as a management benchmark.
  • EBITDA3,991 million yen
    Year on year against the same period last year+¥50 million
  • EBITDA margin15.6 %
    Year on year against the same period last yearIn line with the prior-year period
  • Overseas revenue38.6 億円2026年3月期3Q
    Year on year against the same period last year前年同期38.2億円から増加
  • Orthokeratology lens revenue¥689 million2026年3月期3Q
    Year on year against the same period last year+10.1%
  • 使い捨てコンタクトレンズ最大生産能力6,500 万枚／月
Unit price and quantity metricsThese figures show sales broken down by price and volume.
一人当たりの購入価格が上昇しているとの説明はあるが、数量と単価の実績値はNot disclosed。
Segment results
セグメント別の利益は示されず、売上高のみ。コンタクトレンズ25,013百万円、ケア用品451百万円、その他59百万円。前年同期比はセグメント別にNot disclosed。
Medium-term management plan targets
Target fiscal yearFiscal year ending March 2027
Consolidated revenue¥41 billion
Operating profit¥2.8 billion
EBITDA77.4億円
ROE8.7%
Financial targets
ROE
Fiscal year ended March 2025: actual6.0%
Target for the fiscal year ending March 20278.7%
Market Size / Share
市場は拡大しているとの説明はあるが、市場規模・シェアの数値はNot disclosed。
Number of stores and locations
営業所8、その他駐在11（2025年3月末現在）。期中の出退店数はNot disclosed。
Number of employees
1,396 Number連結、2025年3月末現在
Annual Dividend
Annual dividend per share15円（2026年3月期予定）
Payout ratio
30～40%を目標
Contents of this document
ItemDetails
Document typeEarnings presentation
Fiscal Period CoveredFiscal year ending March 2026, third quarter
Net Sales25,523 million yen (YoY +1.3%)
Operating profit1,294 million yen (YoY +2.2%)
Ordinary income1,310 million yen (YoY +9.6%)
Net income¥905 million (profit attributable to owners of the parent) (YoY +9.8%)
Gross Profit Margin44.9%
Operating profit margin5.1%
Selling, general and administrative expenses10,157 million yen
Full-year earnings forecastNet Sales 37,000 million yen / Operating profit 2,000 million yen / Ordinary income 1,600 million yen / Profit attributable to owners of the parent 1,100 million yen
Progress against full-year forecastNet Sales 69.0% / Operating profit 64.7% / Ordinary income 81.9% / Profit attributable to owners of parent for the quarter 82.3%
Segment resultsセグメント別の利益は示されず、売上高のみ。コンタクトレンズ25,013百万円、ケア用品451百万円、その他59百万円。前年同期比はセグメント別にNot disclosed。
Breakdown of Factors Affecting the ChangeGross profit +¥516 million / Increase in selling, general and administrative expenses -¥488 million / Increase in non-operating income +¥136 million / Increase in non-operating expenses -¥49 million / Increase in extraordinary income +¥77 million / Decrease in extraordinary losses +¥1 million / Increase in taxes and other items -¥112 million
Key KPIsEBITDA 3,991 million yen, EBITDA margin 15.6 %, Overseas revenue 38.6 億円（2026年3月期3Q）, Orthokeratology lens revenue 689 百万円（2026年3月期3Q）, 使い捨てコンタクトレンズ最大生産能力 6,500 万枚／月
Unit price and quantity metrics一人当たりの購入価格が上昇しているとの説明はあるが、数量と単価の実績値はNot disclosed。
Number of stores and locations営業所8、その他駐在11（2025年3月末現在）。期中の出退店数はNot disclosed。
Number of employees1,396 名（連結、2025年3月末現在）
Medium-term management plan targetsTarget fiscal year Fiscal year ending March 2027 / Consolidated revenue ¥41 billion / Operating profit ¥2.8 billion / EBITDA 77.4億円 / ROE 8.7%
Financial targetsEquity ratio Not disclosed / ROE Fiscal year ended March 2025: actual 6.0% / Target for the fiscal year ending March 2027 8.7%
Annual DividendAnnual dividend per share 15円（2026年3月期予定） / Interim and Year-End Breakdown Not disclosed
Payout ratio30～40%を目標
Market Size / Share市場は拡大しているとの説明はあるが、市場規模・シェアの数値はNot disclosed。
New initiatives鴻巣研究所4号棟の竣工と生産能力増強, AI検査・省人化生産ラインの導入, 高酸素透過性シリコーンハイドロゲル乱視用レンズの発売, ヒロインメイク1day UV Mの新色発売, SEEDこどものめ未来プロジェクトの開始, Application to change the market segment to the Tokyo Stock Exchange Standard Market
Items this document does not state (8)
Results for the three months of the current quarterSelf-assessment against the planAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

乱視用レンズの納期遅延が2025年5月に正常化したこと、スペシャリティレンズの需要拡大、生産部門の人員拡大・ベースアップによる人件費増加、シンガポールの物流拠点立ち上げや組織改編検討に伴うアドバイザリー費用などによる販管費増加。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Third-Quarter Financial Results Briefing Materials for the Fiscal Year Ending March 2026 | SEED CO.,LTD. (7743) timely disclosure | Komori